New Delhi: New variant of diabetes medicines introduced by Pharmaceuticals & Medical Devices Bureau of India (PMBI) will be available for sale at affordable prices under Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP).
Chief executive officer of PMBI Ravi Dadhich launched Sitagliptin, a new variant of medicines for diabetes for all under the PMBJP. New variants of medicines Sitagliptin and its combination will be available at least half the cost of branded medicines.
According to a press communique, a pack of 10 tablets of Sitagliptin Phosphate Tablet IP 50mg will be available at the maximum retail price of ₹60. Similarly, the strip of 10 tablets of Sitagliptin Phosphate Tablet IP 100mg can be purchased at ₹100.
A combination of medicines such as Sitagliptin and Metformin Hydrochloride tablets with 50mg/500mg potency can be available for sale at Jan Aushadhi Kendra at ₹65 per strip. Similarly, the combination of Sitagliptin and Metformin Hydrochloride with 50mg/1000mg potency will be sold at ₹70 per strip.
Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. All these variants are available at 60% to 70% lesser prices than branded variants as they are available in price band of ₹162/- to ₹258/- at other medical stores.
Under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana, more than 8700 Pradhan Mantri Bhartiya Janaushadhi Kendras have been opened across the country. These Kendras are selling quality generic medicines, surgical equipment, nutraceuticals and other products.
At present, these Kendras make available more than 1600 medicines and 250 surgical devices including Suvidha Sanitary pads which are sold at ₹1/- per pad. PMBI is committed to ensure regular and sufficient availability of essential medicines at the Jan Aushadhi Kendras and that too with assurance of good quality and affordable prices for citizens.